Company Filing History:
Years Active: 2016-2020
Title: The Innovative Contributions of Herbert Pang
Introduction
Herbert Pang is a notable inventor based in Durham, NC (US), recognized for his significant contributions to the field of cancer therapeutics. With a focus on pancreatic cancer, his work aims to improve prognosis and treatment responsiveness for patients.
Latest Patents
Herbert Pang holds 3 patents that reflect his innovative approach to cancer treatment. His latest patents include methods for developing a prognosis for pancreatic cancer and predicting responsiveness to cancer therapeutics. These methods involve detecting the expression levels of specific biomarkers, such as ANG-2, SDF-1, and VEGF-D, in samples from subjects. By analyzing these expression levels, the effectiveness of VEGF targeting agents in treating cancer can be determined. Additionally, his methods for developing a prognosis include assessing the expression levels of IGFBP-1, PDGF-AA, and at least one of IL-6 or CRP in pancreatic cancer patients.
Career Highlights
Herbert Pang is affiliated with Duke University, where he continues to advance research in cancer therapeutics. His work is pivotal in developing personalized treatment plans that enhance patient outcomes.
Collaborations
Herbert collaborates with esteemed colleagues, including Andrew B. Nixon and Herbert I. Hurwitz, to further his research initiatives and contribute to the scientific community.
Conclusion
Herbert Pang's innovative work in cancer therapeutics exemplifies the impact of research on improving patient care and treatment efficacy. His contributions are vital in the ongoing battle against pancreatic cancer.